Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

SRR8942980

cc2ee258-d24a-50f0-a2bc-b0ce7f276eaf

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
cancer_type_detailed
subtype

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • TGF_BETA_SIGNALING+0.400
  • PROTEIN_SECRETION+0.250
  • PANCREAS_BETA_CELLS+0.070
  • UV_RESPONSE_DN+0.040
  • WNT_BETA_CATENIN_SIGNALING+0.000
  • HEME_METABOLISM-0.050
  • P53_PATHWAY-0.090
  • BILE_ACID_METABOLISM-0.100
  • NOTCH_SIGNALING-0.110
  • ANDROGEN_RESPONSE-0.120

Top 10 suppressed

  • E2F_TARGETS-0.540
  • IL6_JAK_STAT3_SIGNALING-0.530
  • ALLOGRAFT_REJECTION-0.510
  • G2M_CHECKPOINT-0.490
  • INTERFERON_GAMMA_RESPONSE-0.470
  • INFLAMMATORY_RESPONSE-0.460
  • INTERFERON_ALPHA_RESPONSE-0.460
  • MYC_TARGETS_V2-0.440
  • EPITHELIAL_MESENCHYMAL_TRANSITION-0.430
  • APICAL_SURFACE-0.400

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

9 twins match this tumor's tissue · 1 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1SRR23303736
bladder-landscape@3
0.914
2SRR1516063
bladder-landscape@3
0.910
3SRR1516060
bladder-landscape@3
0.910
4SRR1516046
bladder-landscape@3
0.909
5SRR12475149
colon-landscapes@1
0.907
6C3N-03420
lung-landscapes@6
cohortA10.905
7SRR8943008
bladder-landscape@3
0.893
8R247
bladder-landscape@3
0.888
9MDT-AP-2991
medullo-epn-umap@date-based
MedMedulloblastoma0.883
10SRR1516058
bladder-landscape@3
0.880

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 4 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
TGF_BETA_SIGNALING0.400Inavolisib— uncovered
PROTEIN_SECRETION0.250Remibrutinib— uncovered
PANCREAS_BETA_CELLS0.070Cobimetinib— uncovered
UV_RESPONSE_DN0.040Inavolisib— uncovered